Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Review of monoclonal gammopathy of cutaneous significance (MGCS), a paraproteinemia with serious cutaneous sequelae which warrants co-management with hematology and treatment to address underlying Ig- or plasma cell disorder.”
Title: Monoclonal gammopathy of cutaneous significance
Authors: Juliana Berk-Krauss, Misha Rosenbach
You can read the Full Article in the Journal of the American Academy of Dermatology.
More posts featuring Robert Orlowski.
